BiomX Inc. (PHGE)

BiomX Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-37.14	-26.17	-28.32	-36.23	-30.09	-20.56
Depreciation & Amortization	0.88	0.87	2.52	2.57	2.18	0.32
Share-Based Compensation	1.06	1.06	1.53	3.24	2.89	0.94
Other Operating Activities	7.6	2.95	-4.82	2.85	0.57	1.73
Operating Cash Flow	-27.6	-21.29	-29.09	-27.57	-24.45	-17.58
Capital Expenditures	-0.04	-0.05	-0.11	-3.68	-1.01	-1.31
Acquisitions	0.66	0	0	0	0	0
Change in Investments	0	2	-2	19.85	-9.85	21.05
Investing Cash Flow	0.62	1.95	-2.11	16.17	-10.86	19.74
Share Issuance / Repurchase	34.45	7.15	0.29	23.06	0.21	1.88
Debt Issued / Paid	-14.58	-4.25	0	14.23	0	0
Other Financing Activities	20.96	-	-	-	-0.08	59.67
Financing Cash Flow	40.82	2.9	0.29	37.28	0.13	61.55
Exchange Rate Effect	-0.04	0.01	0.11	-0.03	0	0
Net Cash Flow	13.85	-16.44	-30.91	25.88	-35.17	63.72
Free Cash Flow	-27.64	-21.34	-29.2	-31.25	-25.46	-18.89
Free Cash Flow Per Share	-0.44	-0.42	-0.98	-1.20	-1.10	-3.36

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).